Step Pharma
Step Pharma is developing a novel class of oral nucleotide synthesis inhibitors specifically targeting cytidine triphosphate synthase 1 (CTPS1) to induce selective modulation of T and B cell populatio...load more
Step Pharma's Basic Information
Step Pharma's Competitors
Employee Insights
Step Pharma's Top Employees
Erik van den Berg
Chairman
Phone Email
Thien Duc Tran
Chief Development Officer (CDO)
Phone Email
Andy Parker
President and Chief Executive Officer
Phone Email
Philip Beer
Vice President, Head of Research and Translational Medicine
Phone Email
Maureen Higgins
VP, Head of Clinical Operations
Phone Email
Frequently Asked Questions Regarding Step Pharma
Connect with anyone with AroundDeal today!
Whether you're looking to connect with key decision-makers or making remote or global hires, we've got you covered.
✔ GDPR aligned & CCPA compliant✔ Cancel anytime✔ 5 free contacts